Mayne Pharma, which last week revealed earnings were stabilising after years of volatility, has recommended shareholders accept the $7.40 a share bid, which is a 37 per cent premium to the company’s closing share price on Thursday, but a fraction of the $42 it was trading at in 2016. I have a horrible feeling that the $25 NEU was at over a year ago was the peak and we'll end up a similar way to this.
NEU Price at posting:
$13.40 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)